Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes.

Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators.

N Engl J Med. 1998 Aug 13;339(7):436-43.

3.

The role of eptifibatide in patients undergoing percutaneous coronary intervention.

Zeymer U.

Expert Opin Pharmacother. 2007 Jun;8(8):1147-54. Review.

PMID:
17516878
5.

[The clinical use of the GPIIb/IIIa inhibitors eptifibatide and tirofiban in the treatment of acute coronary syndromes of the "non-ST elevation" type].

Galli M, Maggioni AP, Vassanelli C, Tavazzi L.

Ital Heart J Suppl. 2000 Feb;1(2):202-11. Review. Italian.

PMID:
10731377
7.
8.

[Platelet glycoprotein IIb/IIIa inhibitors in coronary artery disease].

Auer J, Berent R, Lassnig E, Weber T, Maurer E, Eber B.

Herz. 2003 Aug;28(5):393-403. Review. German.

PMID:
12928738
9.
10.

An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.

Adgey AA.

Eur Heart J. 1998 Apr;19 Suppl D:D10-21. Review.

PMID:
9597518
11.

Clinical pharmacology of eptifibatide.

Phillips DR, Scarborough RM.

Am J Cardiol. 1997 Aug 18;80(4A):11B-20B. Review.

PMID:
9291241
13.
14.

Eptifibatide: a potent inhibitor of the platelet receptor integrin glycoprotein IIb/IIIa.

O'Shea JC, Tcheng JE.

Expert Opin Pharmacother. 2002 Aug;3(8):1199-210. Review.

PMID:
12150697
15.

Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease.

Lincoff AM, Califf RM, Topol EJ.

J Am Coll Cardiol. 2000 Apr;35(5):1103-15. Review.

16.

Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes.

Bosch X, Marrugat J, Sanchis J.

Cochrane Database Syst Rev. 2013 Oct 18;(10):CD002130. doi: 10.1002/14651858.CD002130.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;(11):CD002130.

PMID:
24136036
17.

Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes.

Bosch X, Marrugat J, Sanchis J.

Cochrane Database Syst Rev. 2013 Nov 8;(11):CD002130. doi: 10.1002/14651858.CD002130.pub4. Review.

PMID:
24203004
18.
19.

Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.

Bhatt DL, Topol EJ.

JAMA. 2000 Sep 27;284(12):1549-58. Review.

PMID:
11000650

Supplemental Content

Support Center